Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
2023 | Nabriva Therapeutics plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 | CI |
2023 | Nabriva Therapeutics plc(OTCPK:NBRV.F) dropped from NASDAQ Composite Index | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
0.00% | 3 | |
+12.07% | 116B | |
+12.34% | 106B | |
-9.13% | 23.89B | |
-2.24% | 21.58B | |
-10.60% | 18.96B | |
-41.25% | 16.96B | |
-14.60% | 16.33B | |
+7.56% | 14.14B | |
+31.57% | 12.02B |
- Stock Market
- Equities
- NBRVF Stock
- News Nabriva Therapeutics plc
- Transcript : Nabriva Therapeutics plc, Q2 2021 Earnings Call, Aug 05, 2021